Literature DB >> 14978141

Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease.

Maria Gendelman1, Toby Hecht, Brent Logan, Sanja Vodanovic-Jankovic, Richard Komorowski, William R Drobyski.   

Abstract

Interleukin-7 has been shown to enhance T cell reconstitution after allogeneic bone marrow transplantation, in part, by expansion of mature donor T cells, but whether IL-7 also exacerbates graft-vs-host disease (GVHD) remains unresolved. To address this issue, we examined the effect of IL-7 on GVHD induction using a well-defined murine GVHD model (B6-->B6AF1/J). Administration of IL-7 to nonirradiated B6AF1/J recipients of B6 T cells resulted in expansion of splenic donor CD4(+) and CD8(+) T cells and increased GVHD mortality. In contrast, administration of IL-7 on the same schedule failed to increase GVHD mortality in either sublethally or lethally irradiated animals that received graded doses of T cells designed to induce varying degrees of GVHD severity. Moreover, IL-7 failed to increase the number of alloreactive T cells when examined in a murine model (B6-->BALB.B) that allowed for direct quantitation of graft-vs-host-reactive T cells. The combination of irradiation and transplantation of alloreactive donor T cells resulted in significantly increased levels of endogenous splenic IL-7 mRNA when compared with nonirradiated transplanted animals, providing a potential explanation for why exogenous IL-7 did not increase GVHD severity in these mice. We conclude that host conditioning modulates the ability of exogenous IL-7 to exacerbate GVHD and that this occurs through induction of endogenous IL-7 production.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978141     DOI: 10.4049/jimmunol.172.5.3328

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

Review 2.  Clinical strategies to enhance posttransplant immune reconstitution.

Authors:  Irwin D Bernstein; Richard L Boyd; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

Review 3.  Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD).

Authors:  Bruce R Blazar; William J Murphy
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

4.  Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation.

Authors:  Miguel-Angel Perales; Jenna D Goldberg; Jianda Yuan; Guenther Koehne; Lauren Lechner; Esperanza B Papadopoulos; James W Young; Ann A Jakubowski; Bushra Zaidi; Humilidad Gallardo; Cailian Liu; Teresa Rasalan; Jedd D Wolchok; Therese Croughs; Michel Morre; Sean M Devlin; Marcel R M van den Brink
Journal:  Blood       Date:  2012-09-25       Impact factor: 22.113

Review 5.  T cell immune reconstitution following lymphodepletion.

Authors:  Kirsten M Williams; Frances T Hakim; Ronald E Gress
Journal:  Semin Immunol       Date:  2007-11-19       Impact factor: 11.130

6.  Prevention of graft-versus-host disease by anti IL-7Ralpha antibody.

Authors:  Brile Chung; Eric P Dudl; Dullei Min; Lora Barsky; Nancy Smiley; Kenneth I Weinberg
Journal:  Blood       Date:  2007-06-26       Impact factor: 22.113

Review 7.  Pathophysiology of acute graft-versus-host disease: recent advances.

Authors:  Yaping Sun; Isao Tawara; Tomomi Toubai; Pavan Reddy
Journal:  Transl Res       Date:  2007-07-03       Impact factor: 7.012

Review 8.  Thymic involution and immune reconstitution.

Authors:  Heather E Lynch; Gabrielle L Goldberg; Ann Chidgey; Marcel R M Van den Brink; Richard Boyd; Gregory D Sempowski
Journal:  Trends Immunol       Date:  2009-06-18       Impact factor: 16.687

9.  Nonalloreactive T cells prevent donor lymphocyte infusion-induced graft-versus-host disease by controlling microbial stimuli.

Authors:  Hao Wei Li; Jessica Sachs; Clarimel Pichardo; Roderick Bronson; Guiling Zhao; Megan Sykes
Journal:  J Immunol       Date:  2012-11-07       Impact factor: 5.422

10.  Association of serum interleukin-7 levels with the development of acute graft-versus-host disease.

Authors:  Robert M Dean; Terry Fry; Crystal Mackall; Seth M Steinberg; Fran Hakim; Daniel Fowler; Jeanne Odom; Jason Foley; Ronald Gress; Michael R Bishop
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.